Efficacy of a Comprehensive School-based Intervention for High-functioning Children With Autism Spectrum Disorder
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT03338530 |
|
Recruitment Status :
Completed
First Posted : November 9, 2017
Last Update Posted : November 9, 2017
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
| Condition or disease | Intervention/treatment | Phase |
|---|---|---|
| Autism Spectrum Disorder | Behavioral: Comprehensive School-Based Intervention | Not Applicable |
Show detailed description
| Study Type : | Interventional (Clinical Trial) |
| Actual Enrollment : | 103 participants |
| Allocation: | Randomized |
| Intervention Model: | Parallel Assignment |
| Intervention Model Description: | The efficacy of the comprehensive school-based intervention (CSBI) was evaluated in a cluster randomized trial (pretest-posttest control group design). School buildings were randomly assigned to receive the CSBI or their typical educational programming. The CSBI was examined for its effect on the social performance/competence, ASD symptoms, and academic skills of children with HFASD compared to children with HFASD that did not receive the intervention. School staff delivered the multi-component intervention during the school year and research staff monitored intervention implementation (fidelity). |
| Masking: | Single (Outcomes Assessor) |
| Masking Description: | Child testing and behavioral observations were completed by evaluators blinded to treatment condition; evaluators consisted of advanced graduate students with training in the specific outcome measures |
| Primary Purpose: | Treatment |
| Official Title: | Efficacy of a Comprehensive School-based Intervention for High-functioning Children With Autism Spectrum Disorder |
| Actual Study Start Date : | August 1, 2013 |
| Actual Primary Completion Date : | July 31, 2017 |
| Actual Study Completion Date : | July 31, 2017 |
| Arm | Intervention/treatment |
|---|---|
|
Experimental: Comprehensive School-Based Intervention
Children with HFASD assigned to the CSBI received social skills groups, computer instruction in emotion recognition, therapeutic activities, and a behavioral reinforcement system (individual daily note) during the school year and their parents participated in monthly parent training. School staff received training prior to the school year and demonstrated fidelity with the protocol. Fidelity was also monitored during the school year by research assistants.
|
Behavioral: Comprehensive School-Based Intervention
School staff administered the 5 components during the school year. Social Skills Groups were conducted 2-3x/wk. for a total of 60-90 min./wk.; each group contained 3-6 students with social impairments. The Individual Daily Note was administered across the school day to reinforce new skills and reduce problem symptoms. Students' performance on targets was linked to home rewards. Mind Reading computer instruction targeting emotion recognition skills was conducted 3x/wk. for a total of 60 min./wk. Therapeutic Activities were conducted 2x/wk. for a total of 40-60 min./wk.; these cooperative activities were designed to practice targeted skills. Parent Training was conducted 1x/month for 60-90 min./session in order to increase home-school communication and integrate the CSBI across settings. |
|
No Intervention: Business-As-Usual (BAU) Control
Children with HFASD in the BAU schools received their typical special education programming as legally-mandated. The programming received by each was carefully monitored per the following: 1) Each student's IEP was reviewed to document the legally mandated services received; 2) For those receiving counseling or speech-language services, the related-service provider completed a survey indicating specific treatment targets and the protocol for service provision; 3) Parents completed a monthly survey of any external therapeutic programming their child may have received; and 4) Fidelity measures designed for the intervention group (with sequencing requirements removed) were completed for the control condition during two 60-minute classroom observations per week by research assistants.
|
- Change from Baseline Cambridge Mindreading Face-Voice Battery for Children (CAM-C) Scores at Follow-up [ Time Frame: Baseline (immediately prior to treatment) and follow-up (immediately following treatment) ]Total score used to assess emotion recognition skills; scores range from 0 to 90, with higher scores indicating better emotion recognition accuracy/skills
- Change from Baseline Social Responsiveness Scale, 2nd Edition, School Age Form (SRS-2) Scores at Follow-up [ Time Frame: Baseline (immediately prior to treatment) and follow-up (immediately following treatment) ]SRS-2 total composite score normative mean = 50 and standard deviation = 10, with higher scores indicating more severe autism spectrum disorder symptoms/impairments
- Change from Baseline Adapted Skillstreaming Checklist (ASC) Scores at Follow-up [ Time Frame: Baseline (immediately prior to treatment) and follow-up (immediately following treatment) ]Total ASC score used to assess social/social-communication skills; scores range from 38 to 190, with higher scores indicating greater use of social/social-communication skills
- Change from Baseline Woodcock-Johnson III Tests of Achievement (WJ III ACH) Scores at Follow-up [ Time Frame: Baseline (immediately prior to treatment) and follow-up (immediately following treatment) ]Standard scores (mean = 100 and standard deviation = 15) used from the Letter Word Identification, Calculation, Spelling, Passage Comprehension, and Writing Samples subtests, with higher scores indicating better academic skills
- Change from Baseline Social Interaction Observation Scale (SIOS) Scores at Follow-up [ Time Frame: Baseline (immediately prior to treatment) and follow-up (immediately following treatment) ]Total SIOS score used to measure the frequency of social interactions during social activities, with higher total scores indicating more social interactions
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
| Ages Eligible for Study: | 6 Years to 12 Years (Child) |
| Sexes Eligible for Study: | All |
| Accepts Healthy Volunteers: | No |
Inclusion Criteria: (1) WISC-IV short form IQ>70 (and VCI or PRI>80); (2) CASL expressive or receptive language score >75; and (3) a score meeting ASD criteria on the ADI-R
Exclusion Criteria: Evidence of psychosis
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03338530
| Principal Investigator: | Christopher J Lopata, PsyD | Institute for Autism Reseach, Canisius College |
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
| Responsible Party: | Canisius College |
| ClinicalTrials.gov Identifier: | NCT03338530 |
| Other Study ID Numbers: |
2012-13#142RENEWAL-Ammend |
| First Posted: | November 9, 2017 Key Record Dates |
| Last Update Posted: | November 9, 2017 |
| Last Verified: | November 2017 |
| Individual Participant Data (IPD) Sharing Statement: | |
| Plan to Share IPD: | Undecided |
| Plan Description: | We are evaluating the appropriate means to make the data available to other researchers (e.g., NDAR) |
| Studies a U.S. FDA-regulated Drug Product: | No |
| Studies a U.S. FDA-regulated Device Product: | No |
|
Psychosocial treatment School intervention Autism Spectrum Disorder |
|
Disease Autistic Disorder Autism Spectrum Disorder Child Development Disorders, Pervasive |
Pathologic Processes Neurodevelopmental Disorders Mental Disorders |

